💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for BioDelivery Sciences International, Inc. (BDSI)
« Back to company indexBDSI Chatter Timeline
Stock Ticker for BDSI
Most Active Tweeters for BDSI
| User | Tweets |
|---|---|
| @PMDiChristina | 5 |
| @Estimize | 4 |
| @newsfilterio | 3 |
| @stock_titan | 3 |
| @EdgarInsider | 3 |
Recent Tweets for BDSI
 |
@r_k39842 @Stocktwits someone ask @BioDeliverySI what the hell happened to lawsuit ans when will $BDSI investor be untrapped?… https://t.co/y7xSrlMJbK 12:08am |
 |
@EarningsAlley BioDelivery Sciences International, Inc. $BDSI held an earnings call on 8/4/2021. Here are the highlights: August 4th 2021, 11:08pm |
 |
@EdgarInsider SEC Form 8-K [Press/News Current Report] filed by $BDSI $BDSIW BIODELIVERY SCIENCES INTERNATIONAL INC https://t.co/39bKWGeUc4 August 4th 2021, 10:08pm |
 |
@SiteFocusHQ $BDSI Earnings Intelligence Analysis of recent earnings identified BioDelivery Sciences International, Inc (NASDAQ:… https://t.co/7Ub0qNcCul August 4th 2021, 8:08pm |
 |
@SeekingAlpha $BDSI - BioDelivery Sciences International, Inc.'s (BDSI) CEO Jeff Bailey on Q2 2021 Results - Earnings Call Transc… https://t.co/SDHpXLb7Jh August 4th 2021, 6:08pm |
 |
@newsfilterio BioDelivery Sciences Reports Mixed Q2 Earnings, Sees FY21 Belbuca Sales At Lower End Of Guidance Range $BDSI $RDY https://t.co/X77uVde3Qt August 4th 2021, 5:08pm |
 |
@StckPro $BDSI NEW ARTICLE : BioDelivery Sciences Reports Mixed Q2 Earnings, Sees FY21 Belbuca Sales At Lower End Of Guidanc… https://t.co/ahQo1pFXwA August 4th 2021, 4:08pm |
 |
@SmallCapsDaily $BDSI BioDelivery Sciences Reports Second Quarter 2021 Results GlobeNewswire https://t.co/4puaVuGXpQ… https://t.co/xvvWtOjHAX August 4th 2021, 3:08pm |
|
@SeekingAlpha $BDSI - BioDelivery Sciences International, Inc. 2021 Q2 - Results - Earnings Call Presentation.… https://t.co/heXM0NmqX9 August 4th 2021, 2:08pm |
 |
@AlertTrade DOWNwithEARNINGS: $BDSI BioDelivery Sciences International, Inc. https://t.co/BS2KvKeMPU ? TradeIdeas via ? https://t.co/VS8RO1bzXJ August 4th 2021, 1:08pm |
 |
@Gregory35057321 $BDSI curling to the upside August 4th 2021, 1:08pm |
 |
@bjen07921 RT @Estimize: The most accurate $BDSI estimate is from @bjen07921, beating 6 other analysts - https://t.co/WB8QYSoDul August 4th 2021, 12:08pm |
 |
@Estimize The most accurate $BDSI estimate is from @bjen07921, beating 6 other analysts - https://t.co/WB8QYSoDul August 4th 2021, 12:08pm |
|
@Estimize $BDSI misses the Estimize EPS Consensus by 2c and the Estimize Revenue Consensus by $0.89M. Reports FQ2 earnings of… https://t.co/QgugvW0qUY August 4th 2021, 12:08pm |
|
@Estimize $BDSI reports FQ2 earnings of 8c EPS and $41.40M Revs - https://t.co/6PgAa5Nqrs August 4th 2021, 12:08pm |
 |
@StockPods $BDSI Earnings Call Today: 8:30 AM EST Webcast: https://t.co/9nLCiS8z2h Signup for the StockPods BETA now: https://t.co/Vma4E2hQ99 August 4th 2021, 12:08pm |
|
@EdgarInsider FORM 8-K [Press/News Current Report] recently SEC filed. $BDSI $BDSIW BIODELIVERY SCIENCES INTERNATIONAL INC https://t.co/caTEAUMwgB August 4th 2021, 12:08pm |
 |
@investor_feed $BDSI 8-K Biodelivery Sciences International (4 Aug, 8:07am) ? BioDelivery Sciences Reports Second Quarter 202… https://t.co/lQIh13QuQT August 4th 2021, 12:08pm |
 |
@otcdynamics $BDSI BioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB™ for the… https://t.co/2PIS6uexMZ August 4th 2021, 12:08pm |
|
@newsfilterio BioDelivery Sciences EPS beats by $0.05, misses on revenue $BDSI https://t.co/8jE0ahx9ZL August 4th 2021, 12:08pm |
 |
@ethanFlare $BDSI - BioDelivery Sciences EPS beats by $0.05, misses on revenue Cap size: small, Float 88.5%, Short Interest 2.7… https://t.co/PNNpTqZ7hu August 4th 2021, 12:08pm |
 |
@MarketCurrents $BDSI - BioDelivery Sciences EPS beats by $0.05, misses on revenue https://t.co/iBtZnuVhNt August 4th 2021, 12:08pm |
 |
@StockNewsBot2 $BDSI BioDelivery Sciences Reports Second Quarter 2021 Results https://t.co/zeUE0r46sS August 4th 2021, 12:08pm |
 |
@stock_titan $BDSI BioDelivery Sciences Reports Second Quarter 2021 Results https://t.co/W6zoM9lIKQ August 4th 2021, 12:08pm |
 |
@sbwcws BioDelivery Sciences enters agreement to acquire U.S., Canadian rights to ELYXYB $BDSI August 4th 2021, 11:08am |
 |
@thestagiritis WW for me so far $CUEN and not found yet IMO waiting for it over VWAP and more volume $BDSI August 4th 2021, 11:08am |
 |
@GapUp4 $BDSI BioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB™ for the… https://t.co/hrMXlooTGu August 4th 2021, 11:08am |
|
@GapUp4 $BDSI BioDelivery Sciences to acquire U.S. and Canadian rights to ELYXYB migraine treatment August 4th 2021, 11:08am |
 |
@MarkoJazbinsek $BDSI had an order at 4 when the news hit, got filled, sold for pennies right away, weak PR: Agreement to Acquire U… https://t.co/94nknDPLXo August 4th 2021, 11:08am |
 |
@Drew2Par Took $BDSI on that news. Great news and didn’t move it. Earnings this morning as well. August 4th 2021, 11:08am |
 |
@picks_horse $BDSI BioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB™ for the… https://t.co/WizLznaj98 August 4th 2021, 11:08am |
|
@ethanFlare $BDSI - BioDelivery Sciences to acquire U.S. and Canadian rights to ELYXYB migraine treatment Cap size: small, Floa… https://t.co/HNyrNMQUo6 August 4th 2021, 11:08am |
 |
@JackofSumTrade $BDSI In @ $4.25. Will add more on sharp dips. News: BioDelivery Sciences Announces Agreement to Acquire U.S. and C… https://t.co/IMXkaps6PC August 4th 2021, 11:08am |
 |
@FlashAlert_me $BDSI [15s. delayed]: Issued Press Release on August 04, 07:30:00: BioDelivery Sciences Announces Agreement to Acqu… https://t.co/0QgJIAO2sj August 4th 2021, 11:08am |
|
@StockNewsBot2 $BDSI BioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB™ for the… https://t.co/UKGMQ6wxrC August 4th 2021, 11:08am |
 |
@James__BondOO7 RT @stock_titan: $BDSI BioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB™ for the Acute T… August 4th 2021, 11:08am |
|
@stock_titan $BDSI BioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB™ for the… https://t.co/q8VrM2lcg1 August 4th 2021, 11:08am |
 |
@PMDiChristina Give us a little ?? $BDSI https://t.co/vQJAxj8luq August 3rd 2021, 7:08pm |
|
@Estimize $BDSI reports before the open tomorrow, Estimize Consensus +0.01 EPS and +0.48M Revs compared to WS - https://t.co/hH4imqYe2I August 3rd 2021, 6:08pm |
 |
@psbfoto RT @PMDiChristina: We still love this look $BDSI https://t.co/ge2cfoasZr August 3rd 2021, 12:08pm |
|
@PMDiChristina We still love this look $BDSI https://t.co/ge2cfoasZr August 2nd 2021, 7:08pm |
 |
@SwingTradeBot 200 DMA Support today: $BDSI $USDU ... https://t.co/LjP7KUcNnp August 2nd 2021, 3:08pm |
|
@investor_feed $BDSI 8-K Biodelivery Sciences International (30 Jul, 4:03pm) ? Submission of Matters to a Vote of Security Ho… https://t.co/N9XsS5RKbf July 30th 2021, 8:07pm |
|
@EdgarInsider Alert [Press/News Current Report] / Form 8-K filed with the SEC $BDSI $BDSIW BIODELIVERY SCIENCES INTERNATIONAL IN… https://t.co/ip0yNvmbpa July 30th 2021, 8:07pm |
|
@FlashAlert_me $BDSI [15s. delayed] filed form 8-K on July 30, 16:03:23: Item5.07: Submission of Matters to a Vote of Security Hol… https://t.co/pEzIoIoh4T July 30th 2021, 8:07pm |
 |
@Market_Newswire $BDSI SEC Filing: 8-K Vote - BIODELIVERY SCIENCES INTERNATIONAL INC (0001103021) July 30 undefined July 30th 2021, 8:07pm |
 |
@Hifl8 $BDSI looking very good for next months after triple bottom. Earnings Release 4 August This is a 8 stock end of… https://t.co/aXgXBOhHSO July 30th 2021, 1:07pm |
 |
@Tickeron $BDSI's Aroon indicator reaches into Uptrend on July 2, 2021. View odds for this and other indicators:… https://t.co/8AvqYuXOmD July 29th 2021, 12:07pm |
 |
@xenofrieza $BDSI Weekly https://t.co/ohfnuLEUBi July 28th 2021, 9:07pm |
|
@Kushal27581726 @theWalrusStreet Any change in your thesis about $BDSI? I’ve bought some September $5 calls, and couldn’t find any… https://t.co/ya4DEovWXZ July 28th 2021, 9:07am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?